Received Dec 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
patient received first dose of Twinrix on 14MAY2025, and they have not received the second dose so far; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (Received 1st dose of Twinrix vaccine on 14-MAY-2025 (batch number P2443, Expiry date 18-SEP-2027)). The patient did not receive the 2nd dose of Twinrix. The patient had incomplete course of vaccination (Verbatim: patient received first dose of Twinrix on 14MAY2025, and they have not received the second dose so far). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-DEC-2025